NY-ESO-1: a promising cancer testis antigen for sarcoma immunotherapy and diagnosis

Chinese Clinical Oncology
Stephen M Smith, O Hans Iwenofu

Abstract

Sarcomas are heterogenous malignant mesenchymal neoplasms. These are often notoriously difficult to treat particularly in the metastatic setting. There is therefore an urgent need for development of better and more efficacious targeted therapies. Cancer testis antigens (CTAs) are a family of proteins in which aberrant gene-activation and subsequent high level mRNA expression, are restricted to testicular germ cells and are seen in certain malignancies. Importantly, the restriction of this class of antigens to testicular germ cells and malignancies and not somatic tissue, makes them an excellent choice for targeted immunotherapy. The NY-ESO-1is the most immunogenic of CTA and has, of late, become well-studied for its diagnosis and potential treatment implications in sarcomas. This paper reviews both the role of NY-ESO-1 in the diagnosis of sarcomas, as well as the implications of this CTA in vaccine development and treatment of sarcomas.

Citations

Oct 27, 2018·Current Treatment Options in Oncology·Sarah Abaricia, Angela C Hirbe
Mar 26, 2019·Human Antibodies·Zahra Taherian-Esfahani, Sepideh Dashti
Feb 22, 2021·Japanese Journal of Clinical Oncology·Eiji NakataToshifumi Ozaki
Aug 3, 2021·Frontiers in Immunology·Eric de SousaMarkus Maeurer
Jan 20, 2022·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Ozgur Tanriverdi, Aysegul Yildiz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Jason A DubovskyJavier A Pinilla-Ibarz
The British Journal of Dermatology
M LüftlAchim A Jungbluth
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Evgeny YakirevichMurray B Resnick
© 2022 Meta ULC. All rights reserved